345983-44-0Relevant academic research and scientific papers
An efficient synthesis of the taxane-derived anticancer agent ABT-271
DeMattei,Leanna,Li,Nichols,Rasmussen,Morton
, p. 3330 - 3337 (2007/10/03)
ABT-271, 1, has been identified as a promising anticancer agent. ABT-271 is a novel taxane possessing a C9-(R)-hydroxyl group as opposed to a C9-ketone which is present in Taxol and Taxotere. To further evaluate ABT-271 as a potential anticancer agent, an efficient synthesis was developed which allows the large scale synthesis of ABT-271. Ketalization of the 7,9-diol of 9-DHAB-III, 2, allows selective removal of the C13-acetate with phenyllithium. The resulting C13-hydroxyl group is then acylated using LiHMDS and β-lactam 22 to give ABT-271 in protected form. The protecting groups were removed first by acidic hydrolysis followed by basic hydrolysis to provide ABT-271. Application of this synthetic sequence provided over 600 g of ABT-271, 1.
Synthesis and Biological Evaluation of C-3'-Modified Analogs of 9(R)-Dihydrotaxol
Li, Leping,Thomas, Sheela A.,Klein, Larry L.,Yeung, Clinton M.,Maring, Clarence J.,et al.
, p. 2655 - 2663 (2007/10/02)
Taxol (1) is considered a most exciting new drug in cancer chemotherapy.The promising antitumor activity of 9(R)-dihydrotaxol (3) encouraged us to further explore the structure-activity relationship of this new member of the taxane family.Studies indicate
